(S (NP-SBJ (NN Interferon-gamma)) (VP (VBZ potentiates) (NP (NP-COOD (NP (DT the) (JJ antiviral) (NN activity)) (CC and) (NP (DT the) (NN expression))) (PP (IN of) (NP (JJ interferon-stimulated) (NNS genes))) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN interferon-alpha))) (PP (IN in) (NP (NN U937) (NNS cells)))))) (. .))
(S (NP-SBJ (NP (NN Binding)) (PP (IN of) (NP (NP (NN type) (CD I) (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN (beta IFN-alpha))) (-RRB- -RRB-)))) (PP (TO to) (NP (JJ specific) (NNS receptors)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (JJ rapid) (JJ transcriptional) (NN activation)) (, ,) (ADJP (JJ independent) (PP (IN of) (NP (NN protein) (NN synthesis)))) (, ,) (PP (IN of) (NP (NP (NP (JJ IFN-alpha-stimulated) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NNS ISGs)) (-RRB- -RRB-))) (PP (IN in) (NP-COOD (NP (JJ human) (NNS fibroblasts)) (CC and) (NP (NP-COOD (NP (NN HeLa)) (CC and) (NP (NN Daudi))) (NN cell) (NNS lines))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN binding)) (PP (IN of) (NP (NP (NN ISGF3)) (PRN (-LRB- -LRB-) (NP (JJ IFN-stimulated) (NN gene) (NN factor) (CD 3)) (-RRB- -RRB-)))) (PP (TO to) (NP (DT the) (VBN conserved) (NP (JJ IFN-stimulated) (NN response) (NN element)) (PRN (-LRB- -LRB-) (NP (NN ISRE)) (-RRB- -RRB-))))) (VP (VBZ results) (PP (IN in) (NP (JJ transcriptional) (NN activation)))) (. .))
(S (NP-SBJ-40 (DT This) (NN factor)) (VP (VBZ is) (VP (VBN composed) (NP (-NONE- *-40)) (PP (IN of) (NP-COOD (NP (NP (NP (DT a) (JJ DNA-binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN ISGF3) (NN gamma)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-41 (WDT which)) (S (NP-SBJ (-NONE- *T*-41)) (ADVP (RB normally)) (VP (VBZ is) (ADJP-PRD (JJ present) (PP (IN in) (NP (DT the) (NN cytoplasm))))))) (, ,)) (CC and) (NP (NP (JJ other) (JJ IFN-alpha-activated) (NNS proteins)) (SBAR (WHNP-42 (WDT which)) (S (NP-SBJ (-NONE- *T*-42)) (VP (VBP preexist) (PP (IN as) (NP (NP (JJ latent) (JJ cytoplasmic) (NNS precursors)) (PRN (-LRB- -LRB-) (NP (NN ISGF3) (NN alpha)) (-RRB- -RRB-)))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP-SBJ (NP (NN ISG) (NN expression)) (PP (IN in) (NP (DT the) (JJ monocytic) (NN U937) (NN cell) (NN line)))) (VP (VBZ differs) (PP (IN from) (NP (NP (JJS most) (NN cell) (NNS lines)) (VP (ADVP-TMP (RB previously)) (VBN examined) (NP (-NONE- *)))))))))) (. .))
(S-COOD (S (NP-SBJ (NN U937) (NNS cells)) (VP (VBP express) (NP (NP-COOD (CC both) (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NN IFN) (NNS receptors)))) (, ,) (CC but) (S (NP-SBJ-43 (RB only) (NN IFN-alpha)) (VP (VBZ is) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-43)) (VP (VBG inducing) (NP (JJ antiviral) (NN protection)) (PP (IN in) (NP (DT these) (NNS cells))))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NN Pretreatment)) (PP (IN with) (NP (NN IFN-gamma)))) (VP (VBZ potentiates) (NP (DT the) (JJ IFN-alpha-induced) (NN protection)))) (, ,) (CC but) (S (NP-SBJ (NP (NN IFN-gamma)) (ADVP (RB alone))) (VP (VBZ does) (RB not) (VP (VB have) (NP (DT any) (JJ antiviral) (NN activity))))) (. .))
(S (NP-SBJ (NP (NN ISG15) (NN mRNA) (NN accumulation)) (PP (IN in) (NP (NN U937) (NNS cells)))) (VP-COOD (VP (VBZ is) (RB not) (ADJP-PRD (JJ detectable)) (PP-TMP (IN before) (NP (NP (CD 6) (NN h)) (PP (IN of) (NP (NN IFN-alpha) (NN treatment)))))) (, ,) (VP (VBZ peaks) (PP-TMP (IN at) (NP (CD 24) (NN h)))) (, ,) (CC and) (VP (VBZ requires) (NP (NN protein) (NN synthesis)))) (. .))
(S (SBAR-ADV (IN Although) (S (NP-SBJ (NP (NN IFN-gamma)) (ADVP (RB alone))) (VP (VBZ does) (RB not) (VP (VB induce) (NP (NN ISG) (NN expression)))))) (, ,) (NP-SBJ (NN IFN-gamma) (NN pretreatment)) (ADVP (RB markedly)) (VP (VP-COOD (VP (VBZ increases) (NP (-NONE- *RNR*-108))) (CC and) (VP (VBZ hastens) (NP (-NONE- *RNR*-108)))) (NP-COOD-108 (NP (NN ISG) (NN expression)) (CC and) (NP (JJ transcriptional) (NN induction)))) (. .))
(S (NP-SBJ (NP (JJ Nuclear) (NNS extracts)) (VP (VBN assayed) (NP (-NONE- *)) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN ISRE) (NN binding) (NNS factors))))) (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))))) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-44 (NN ISGF3)) (VP (VBZ is) (VP (VBN induced) (NP (-NONE- *-44)) (PP (IN by) (NP-LGS (NN IFN-alpha))) (PP-TMP (IN within) (NP (CD 6) (NN h))) (PP (IN from) (NP (JJ undetectable) (JJ basal) (NNS levels))) (PP (IN in) (NP (JJ untreated) (NN U937) (NNS cells)))))))) (. .))
(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (NP (NN ISGF3) (NN alpha)) (, ,) (NP (NP (DT the) (JJ latent) (NN component)) (PP (IN of) (NP (NN ISGF3)))) (, ,)))) (VP (VBZ occurs) (ADVP-TMP (RB rapidly))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (NN increase)) (PP (IN in) (NP (NN ISGF3) (NN activity)))) (ADVP (RB ultimately)) (VP (VBZ correlates) (PP (IN with) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN ISGF3) (NN gamma))) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS-COOD (NP (NN IFN-alpha)) (CC or) (NP (NN IFN-gamma)))))))) (. .))
(S (-LRB- -LRB-) (NP-SBJ-109 (NN ABSTRACT)) (VP (VBN TRUNCATED) (NP (-NONE- *-109)) (PP (IN AT) (NP (CD 250) (NNS WORDS)))) (-RRB- -RRB-))
